BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 24749250)

  • 1. [Mean platelet volume: interactions with platelet aggregation activity and glycoprotein IIb-IIIa and Ib expression levels].
    Khaspekova SG; Ziuriaev IT; Iakushkin VV; Naĭmushin IaA; Sirotkina OV; Zaĭtseva NO; Ruda MIa; Mazurov AV
    Biomed Khim; 2014; 60(1):94-108. PubMed ID: 24749250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet aggregation upon acetylsalicylic acid and clopidogrel treatment and glycoprotein IIb/IIIa content in patients with acute coronary syndrome].
    Khaspekova SG; Ziuriaev IT; Iakushkin VV; Golubeva NV; Ruda MIa; Mazurov AV
    Kardiologiia; 2011; 51(7):4-7. PubMed ID: 21878077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein IIb-IIIa content and platelet aggregation in healthy volunteers and patients with acute coronary syndrome.
    Yakushkin VV; Zyuryaev IT; Khaspekova SG; Sirotkina OV; Ruda MY; Mazurov AV
    Platelets; 2011; 22(4):243-51. PubMed ID: 21329420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors influencing platelet aggregation in patients with acute coronary syndrome].
    Mazurov AV; Ziuriaev IT; Khaspekova SG; Iakushkin VV; Sirotkina OV; Ruda MIa
    Ter Arkh; 2014; 86(9):83-9. PubMed ID: 25518511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships of glycoproteins IIb-IIIa and Ib content with mean platelet volume and their genetic polymorphisms.
    Khaspekova SG; Zyuryaev IT; Yakushkin VV; Sirotkina OV; Zaytseva NO; Ruda MY; Panteleev MA; Mazurov AV
    Blood Coagul Fibrinolysis; 2014 Mar; 25(2):128-34. PubMed ID: 23941967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Variations in glycoprotein IIb-IIIa (alphaIIb/beta3-integrin) content in healthy donors. Influence on platelet aggregation activity and efficacy of aspirin action].
    Khaspekova SG; Sirotkina OV; Shimanova IuV; Mazurov AV
    Biomed Khim; 2008; 54(3):361-71. PubMed ID: 18712091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists.
    Michelson AD; Furman MI; Goldschmidt-Clermont P; Mascelli MA; Hendrix C; Coleman L; Hamlington J; Barnard MR; Kickler T; Christie DJ; Kundu S; Bray PF
    Circulation; 2000 Mar; 101(9):1013-8. PubMed ID: 10704169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
    Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
    Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
    Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54.
    Naimushin YA; Mazurov AV
    Biochemistry (Mosc); 2005 Jul; 70(7):782-9. PubMed ID: 16097942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?
    Silva MA; Donovan JL; Gandhi PJ; Volturo GA
    Vasc Health Risk Manag; 2006; 2(1):39-48. PubMed ID: 17319468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PlA(1)/PlA(2) polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty.
    Verdoia M; Pergolini P; Camaro C; Restifo M; Rolla R; Schaffer A; Di Giovine G; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):411-8. PubMed ID: 23412353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
    Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib.
    Walsh MT; Dinan TG; Condren RM; Ryan M; Kenny D
    Life Sci; 2002 May; 70(26):3155-65. PubMed ID: 12008098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increased platelet aggregation induced activity by anti-glycoprotein IIb/IIIa antibody in patients with acute coronary syndrome].
    Voskoboĭ IV; Mazurov AV
    Kardiologiia; 2004; 44(10):64-70. PubMed ID: 15477794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of platelet surface receptors and early changes in platelet function in patients with STEMI treated with abciximab and clopidogrel versus clopidogrel alone.
    Konopka A; Spychalska J; Sitkiewicz D; Zdebska E; Pilichowska I; Piotrowski W; Stepińska J
    Am J Cardiovasc Drugs; 2007; 7(6):433-9. PubMed ID: 18076210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation].
    Morel O; Viellard C; Faure A; Jesel L; Ohlmann P; Desprez D; Chauvin M; Roul G; Grunebaum L; Bareiss P
    Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):21-9. PubMed ID: 17343035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphorylation in human platelets during shear stress-induced platelet aggregation (SIPA) is regulated by glycoprotein (GP) Ib/IX as well as GP IIb/IIIa and requires intact cytoskeleton and endogenous ADP.
    Oda A; Yokoyama K; Murata M; Tokuhira M; Nakamura K; Handa M; Watanabe K; Ikeda Y
    Thromb Haemost; 1995 Aug; 74(2):736-42. PubMed ID: 8585015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The molecular mechanisms of platelets activation in patients with cerebrovascular disease].
    Sirotkina OV; Laskovets AB; Goldobin VV; Topanova AA; Karelov DV; Vavilova TV
    Biomed Khim; 2015; 61(5):606-12. PubMed ID: 26539867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes.
    Braunwald E; Angiolillo D; Bates E; Berger PB; Bhatt D; Cannon CP; Furman MI; Gurbel P; Michelson AD; Peterson E; Wiviott S
    Clin Cardiol; 2008 Mar; 31(3 Suppl 1):I2-9. PubMed ID: 18481818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.